In the declarations of St Vincent and Kos, a number of therapeutic goals were formulated for the treatment of all patients with diabetes, aiming at better health, more efficient prevention of debilitating secondary complications and greater life expectancy in dignity and social acceptance. Such efforts have lead to the publication of consensus guidelines for the treatment of children and adolescents with diabetes. This text analyzes the impact of these efforts, with regard to diabetic neurovascular complications in children and adolescents. It aims to collect evidence for progress in clinical, epidemiological and basic research on the quality of diabetes care and its influence on diabetic angiopathy. When compared to the results presented at previous workshops, the present proceedings document the progress of paediatric diabetology.
Sprache
Verlagsort
Zielgruppe
Illustrationen
Maße
Gewicht
ISBN-13
978-3-8055-6720-6 (9783805567206)
Schweitzer Klassifikation
Part 1 Vascular and neural complications: molecular mechanisms of diabetic angiopathy clues for innovative therapeutic interventions; genetic markers of increased susceptibility to diabetic nephropathy; biochemical markers of diabetic microangiopathy; diabetic glomerulopathy in young IDDM patients; predictive value of tubular markers for the development of microalbuminuria in adolescents with diabetes; factors modifying the effect of hyperglycemia on the development of retinopathy in adolescents with diabetes; autonomic neuropathy - diagnosis and impact on health in adolescents with diabetes; macroangiopathy - does it play a role in young people?. Part 2 Prevention of complications - assessment of the quality of care - clinical and technical aspects: approaches to quality of control in diabetes care; structure quality management in paediatric diabetes care; process quality management in paediatric diabetes care; outcome of quality management in paediatric diabetes care; laboratory standards in the assessment of the quality of care; methods of assessing the quality of diabetes care; computer programs and datasheets. Part 3 Approaches to better care: non-evidence-based concepts are still established in the treatment of IDDM; eating disorders in young women with type 1 diabetes; improvements and new potentials in pharmacological therapy of diabetes mellitus in children and adolescents. Part 4 Abstracts: poster presentations. Part 5 Concluding remarks: perspectives of quality control in diabetes treatments at the end of the century - facts and visions.
